SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Agouron Pharmaceuticals (AGPH)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
6136 24 0 AGPH
Emcee:  Bhag Karamchandani Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4686 Steve: You're going to wear yourself out! It won't go up until it doescaram(o)uche-7/1/1998
4685 Rick, are we expecting further news on Remune tomorrow, or are the studies rSteve Fancy-7/1/1998
4684 Peter: Yeah.... I had thought that it would be clear that we're probablyscaram(o)uche-7/1/1998
4683 Peter, My understanding is that JE-2147 was licensed by AGPH because in vitro, Vector1-7/1/1998
4682 Here is a more detailed summary of resistance issues. healthcg.com Sounds likJoe E.-7/1/1998
4681 Glaxo Wellcome Says Aprenavir Drug Might Help Immune System Dow Jones NewswSteve Fancy-7/1/1998
4680 Drug-Resistant AIDS Strains Worry Researchers at Parley By MICHAEL WALDHOLZ Steve Fancy-7/1/1998
4679briefing.newsalert.comsam-7/1/1998
4678 I did an altavista search KNI-272 (Japan Energy's 1st generation PI). TherPeter Singleton-7/1/1998
4677 I can't help believe Peter and the Agouron Team have the ability to select billkirn-7/1/1998
4676 There's tons out there about KNI-272 and derivatives, including some work tscaram(o)uche-7/1/1998
4675 The last four posts (4670-4673) neatly summarize and archive all four of AGPSteve Fancy-7/1/1998
4674 Folks, if you haven't read Dr. Joseph Eron's review of the Sustiva dataPeter Singleton-7/1/1998
4673 AGOURON PHARMACEUTICALS INC - Acquires New HIV Protease Inhibitor From Japan EnSteve Fancy-7/1/1998
4672 AGOURON PHARMACEUTICALS INC - Acquires New Anti-HIV Drug from Shionogi [85] CaSteve Fancy-7/1/1998
4671 Alanex Corp (NASDAQ:AGPH) in pact with Zeneca unit <i><b>Reuters, Steve Fancy-7/1/1998
4670 Agouron and The Immune Response Corporation to Collaborate on CommercializationSteve Fancy-7/1/1998
4669 Frustrating to hear Crossen crowing about increased competition as though it hascaram(o)uche-7/1/1998
4668 World AIDS Conference Data Supports Dual Protease Inhibitor Therapy With NorvirSteve Fancy-7/1/1998
4667 One big question: Why did Merck sell its stake in DuPont-Merck to DD, leaving John Metcalf-7/1/1998
4666 Another treatment opinion: "Leading experts at the XII World AIDS ConferenIzzy-7/1/1998
4665 HIV Protease Drug Stocks Plummet As Potential New Therapy Emerges Steve Fancy-6/30/1998
4664 US OPTIONS/Agouron vols spike as stock stumbles Steve Fancy-6/30/1998
4663 Sorry for butting in. Intent to treat analysis includes all enrolled patients biodoc-6/30/1998
4662 They do acknowledge they used three different methods, but it is hard to figuremargie-6/30/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News